Dong‐Fu Feng

1.7k total citations
56 papers, 1.3k citations indexed

About

Dong‐Fu Feng is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Neurology. According to data from OpenAlex, Dong‐Fu Feng has authored 56 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 18 papers in Cellular and Molecular Neuroscience and 18 papers in Neurology. Recurrent topics in Dong‐Fu Feng's work include Traumatic Brain Injury and Neurovascular Disturbances (15 papers), Neurogenesis and neuroplasticity mechanisms (13 papers) and Nerve injury and regeneration (11 papers). Dong‐Fu Feng is often cited by papers focused on Traumatic Brain Injury and Neurovascular Disturbances (15 papers), Neurogenesis and neuroplasticity mechanisms (13 papers) and Nerve injury and regeneration (11 papers). Dong‐Fu Feng collaborates with scholars based in China and Thailand. Dong‐Fu Feng's co-authors include Zhao-Liang Sun, Xueyuan Li, Sheng‐Hua Chu, Yan‐Bin Ma, Yuan‐Bo Pan, Xi Yang, Jia Li, Hongjiang Li, Lei Gu and Pucha Jiang and has published in prestigious journals such as SHILAP Revista de lepidopterología, Neuroscience and Science Advances.

In The Last Decade

Dong‐Fu Feng

56 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dong‐Fu Feng China 22 615 332 226 225 181 56 1.3k
Daniel Crooks United Kingdom 17 425 0.7× 224 0.7× 168 0.7× 125 0.6× 191 1.1× 42 1.3k
Tetsuya Ueba Japan 23 662 1.1× 478 1.4× 293 1.3× 191 0.8× 164 0.9× 112 1.8k
Zhongcheng Wang China 20 229 0.4× 281 0.8× 163 0.7× 199 0.9× 109 0.6× 74 1.1k
Susan Noell Germany 21 717 1.2× 310 0.9× 160 0.7× 248 1.1× 141 0.8× 33 1.8k
Kun Jin United States 12 815 1.3× 315 0.9× 158 0.7× 410 1.8× 164 0.9× 19 1.5k
Camelia‐Maria Monoranu Germany 20 402 0.7× 339 1.0× 109 0.5× 155 0.7× 140 0.8× 54 1.4k
Melanie‐Jane Hannocks Germany 13 374 0.6× 273 0.8× 103 0.5× 476 2.1× 95 0.5× 16 1.3k
Li‐Ru Zhao United States 18 424 0.7× 430 1.3× 247 1.1× 193 0.9× 64 0.4× 41 1.2k
Radim Jančálek Czechia 19 280 0.5× 159 0.5× 97 0.4× 261 1.2× 148 0.8× 75 1.4k

Countries citing papers authored by Dong‐Fu Feng

Since Specialization
Citations

This map shows the geographic impact of Dong‐Fu Feng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dong‐Fu Feng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dong‐Fu Feng more than expected).

Fields of papers citing papers by Dong‐Fu Feng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dong‐Fu Feng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dong‐Fu Feng. The network helps show where Dong‐Fu Feng may publish in the future.

Co-authorship network of co-authors of Dong‐Fu Feng

This figure shows the co-authorship network connecting the top 25 collaborators of Dong‐Fu Feng. A scholar is included among the top collaborators of Dong‐Fu Feng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dong‐Fu Feng. Dong‐Fu Feng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Di, et al.. (2023). Intravitreal injection of Huperzine A promotes retinal ganglion cells survival and axonal regeneration after optic nerve crush. Frontiers in Cellular Neuroscience. 17. 1145574–1145574. 5 indexed citations
2.
Chen, Di, Xu Han, Shuo Yang, et al.. (2023). Knockdown of Porf-2 restores visual function after optic nerve crush injury. Cell Death and Disease. 14(8). 570–570. 1 indexed citations
3.
Zhu, Liang, et al.. (2020). CRMP2 improves memory deficits by enhancing the maturation of neuronal dendritic spines after traumatic brain injury. Experimental Neurology. 328. 113253–113253. 8 indexed citations
4.
Li, Hongjiang, et al.. (2019). Inhibition of miRNA-21 promotes retinal ganglion cell survival and visual function by modulating Müller cell gliosis after optic nerve crush. Experimental Cell Research. 375(2). 10–19. 20 indexed citations
5.
Huang, Guohui, et al.. (2018). 4-Phenylbutyrate Ameliorates Anxiety Disorder by Inhibiting Endoplasmic Reticulum Stress after Diffuse Axonal Injury. Journal of Neurotrauma. 36(11). 1856–1868. 5 indexed citations
6.
Li, Hongjiang, et al.. (2018). Inhibition of miR-21 ameliorates excessive astrocyte activation and promotes axon regeneration following optic nerve crush. Neuropharmacology. 137. 33–49. 40 indexed citations
7.
Yang, Xi, Guohui Huang, Hongjiang Li, et al.. (2017). Rac1 Guides Porf-2 to Wnt Pathway to Mediate Neural Stem Cell Proliferation. Frontiers in Molecular Neuroscience. 10. 172–172. 9 indexed citations
8.
Li, Hongjiang, Hongxiu Han, & Dong‐Fu Feng. (2016). Rapid increase in cystic volume of an anaplastic astrocytoma misdiagnosed as neurocysticercosis: A case report. Oncology Letters. 12(4). 2825–2827. 5 indexed citations
9.
Huang, Guohui, Xi Yang, Xing Jin, et al.. (2016). Porf-2 Inhibits Neural Stem Cell Proliferation Through Wnt/β-Catenin Pathway by Its GAP Domain. Frontiers in Cellular Neuroscience. 10. 85–85. 13 indexed citations
10.
Chu, Sheng‐Hua, et al.. (2013). Inhibition of human glioma U251 cells growth in vitro and in vivo by hydroxyapatite nanoparticle-assisted delivery of short hairpin RNAs against SATB1. Molecular Biology Reports. 41(2). 977–986. 17 indexed citations
11.
Chu, Sheng‐Hua, Yan‐Bin Ma, Dong‐Fu Feng, et al.. (2012). Upregulation of SATB1 is associated with the development and progression of glioma. Journal of Translational Medicine. 10(1). 149–149. 46 indexed citations
12.
Chu, Sheng‐Hua, Yan‐Bin Ma, Dong‐Fu Feng, Zhiqiang Li, & Pucha Jiang. (2012). Correlation between SATB1 and Bcl-2 expression in human glioblastoma multiforme. Molecular Medicine Reports. 7(1). 139–143. 19 indexed citations
13.
Chu, Sheng‐Hua, Dong‐Fu Feng, Yan‐Bin Ma, & Zhiqiang Li. (2012). Hydroxyapatite nanoparticles inhibit the growth of human glioma cells in vitro and in vivo. International Journal of Nanomedicine. 7. 3659–3659. 63 indexed citations
14.
Chu, Sheng‐Hua, et al.. (2011). Elevated expression of solute carrier family 22 member 18 increases the sensitivity of U251 glioma cells to BCNU. Oncology Letters. 2(6). 1139–1142. 12 indexed citations
15.
Yang, Xi, et al.. (2010). From the vascular microenvironment to neurogenesis. Brain Research Bulletin. 84(1). 1–7. 22 indexed citations
16.
Liu, Yong, et al.. (2009). Treatment of optic nerve injury by transplanting hBDNF-GFP gene transfected neural stem cells. Zhonghua chuangshang zazhi. 25(5). 456–460. 1 indexed citations
17.
Li, Xueyuan & Dong‐Fu Feng. (2009). Diffuse axonal injury: Novel insights into detection and treatment. Journal of Clinical Neuroscience. 16(5). 614–619. 88 indexed citations
18.
Chu, Sheng‐Hua, Dong‐Fu Feng, Xueyuan Li, et al.. (2009). c-Met-targeted RNA interference inhibits growth and metastasis of glioma U251 cells in vitro. Journal of Neuro-Oncology. 93(2). 183–189. 29 indexed citations
19.
Chu, Sheng‐Hua, et al.. (2008). Stabilization of hepatocyte growth factor mRNA by hypoxia-inducible factor 1. Molecular Biology Reports. 36(7). 1967–1975. 31 indexed citations
20.
Chu, Sheng‐Hua, et al.. (2007). c-Met Antisense Oligodeoxynucleotides as a Novel Therapeutic Agent for Glioma: In Vitro and In Vivo Studies of Uptake, Effects, and Toxicity. Journal of Surgical Research. 141(2). 284–288. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Daniel Crooks Breakdown of academic impact, for papers by Tetsuya Ueba Breakdown of academic impact, for papers by Zhongcheng Wang Breakdown of academic impact, for papers by Susan Noell Breakdown of academic impact, for papers by Kun Jin Breakdown of academic impact, for papers by Camelia‐Maria Monoranu Breakdown of academic impact, for papers by Melanie‐Jane Hannocks Breakdown of academic impact, for papers by Li‐Ru Zhao Breakdown of academic impact, for papers by Radim Jančálek
Rankless by CCL
2026